Tolerance and Pharmacokinetics of TQB2450

NCT03460457 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor

Interventions

DRUG: TQB2450

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.